Premium Only Content

Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). The Company has successfully completed a Phase 3 study for HyBryte™ and is now negotiating a confirmatory Phase 3 pivotal study design with the US Food & Drug Administration, while also evaluating/pursuing potential HyBryte™ marketing approval ex-U.S. with the successfully completed Phase 3 study. Visit SNGXinfo.com to learn more.
-
5:56:35
JuicyJohns
6 hours ago $2.76 earned🟢#1 REBIRTH PLAYER 10.2+ KD🟢$500 GIVEAWAY SATURDAY!
55K1 -
15:32
Scammer Payback
5 hours agoTormenting the Scammer Who Did This
2.95K12 -
17:28
IsaacButterfield
9 hours ago $0.35 earnedThe Government Just Banned Free Speech in the UK
3.99K3 -
2:01:46
Tim Pool
19 hours agoIs Trump Still Winning? | The Culture War LIVE Debate
167K207 -
5:22
Michael Heaver
13 hours agoBritain's Enraged Voters Reject EXTREME Agenda
11.9K1 -
1:13:41
Rebel News
2 hours agoNo trade deal for Carney, Christian cancelled in BC Bible Belt, Liberal bail reform | Rebel Roundup
15.2K6 -
DVR
The Drew Allen Show on DailyClout
2 hours ago"Russiagate Is ‘Crime of the Century’"
10.5K2 -
1:20:41
Steven Crowder
5 hours agoBill Burr Flames Out on Conservatives, Whites, and... Ben Shapiro
227K146 -
56:58
The Rubin Report
4 hours agoHow to Protect Yourself from Toxic Beliefs | Eckhart Tolle
52.4K25 -
1:39:30
The Mel K Show
3 hours agoMORNINGS WITH MEL K -Collateral Consequences of The Russia Hoax Must Be Addressed! 8-1-25
32.8K10